The productivity limit of manufacturing blood cell therapy in scalable stirred bioreactors-Reference-Cited by-同舟云学术

The productivity limit of manufacturing blood cell therapy in scalable stirred bioreactors

Published:2017-04-03 Issue:1 Volume:12 Page:e368-e378
ISSN:1932-6254
Container-title:Journal of Tissue Engineering and Regenerative Medicine
language:en
Short-container-title:J Tissue Eng Regen Med

Author:

Bayley Rachel¹,Ahmed Forhad¹,Glen Katie¹,McCall Mark¹,Stacey Adrian¹,Thomas Robert¹

Affiliation:

1. Centre for Biological Engineering (Holywell Park), Wolfson School of Mechanical and Manufacturing Engineering; Loughborough University; Loughborough Leicestershire UK

Funder

Wellcome Trust

Engineering and Physical Sciences Research Council

Publisher

Wiley

Subject

Biomedical Engineering,Biomaterials,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/term.2337/fullpdf

Reference45 articles.

1. Drug-loaded erythrocytes: on the road toward marketing approval;Bourgeaux;Drug Des Devel Ther,2016

2. Survival of red blood cells after transfusion: processes and consequences;Bosman;Front Physiol,2013

3. The single-molecule mechanics of the latent TGF-β1 complex;Buscemi;Curr Biol,2011

4. Production of embryonic and fetal-like red blood cells from human induced pluripotent stem cells;Chang;PLoS One,2011

5. Animal-cell damage in sparged bioreactors;Chisti;Trends Biotechnol,2000

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progresses in overcoming the limitations of in vitro erythropoiesis using human induced pluripotent stem cells;Stem Cell Research & Therapy;2024-05-15

2. A comparative study of two routinely used protocols for ex vivo erythroid differentiation;Blood Cells, Molecules, and Diseases;2024-05

3. Engineering inducible signaling receptors to enable erythropoietin-free erythropoiesis;2024-04-12

4. A heterozygousCEBPAmutation disrupting the bZIP domain causes MDS disease progression;2023-07-26

5. Current status of red blood cell manufacturing in 3D culture and bioreactors;Blood Research;2023-04-07